Company Overview
About Accuryn
Accuryn is a critical care hemodynamic monitoring system developed by Retia Medical, a medical device company headquartered in Ann Arbor, Michigan. The Accuryn Monitoring System provides continuous, real-time measurement of cardiac output, stroke volume, and fluid responsiveness in critically ill patients — parameters that are essential for guiding hemodynamic management in the intensive care unit (ICU) but historically required invasive pulmonary artery catheter (PAC) placement to measure. Retia Medical's proprietary pulse contour analysis algorithm enables continuous cardiac output monitoring using standard arterial line waveforms already present in most ICU patients, without requiring additional invasive access.
Business Model & Competitive Advantage
Accuryn has received FDA 510(k) clearance and is commercially available in US hospital ICU and high-acuity settings. The system integrates with existing patient monitors and electronic health record (EHR) systems, providing hemodynamic parameters in a format familiar to intensivists and anesthesiologists. The clinical value proposition centers on enabling individualized, goal-directed fluid therapy — using real-time cardiac output and fluid responsiveness data to guide IV fluid administration decisions — which evidence suggests can reduce complications from both under- and over-resuscitation in septic shock, post-surgical, and other critically ill patient populations.
Competitive Landscape 2025–2026
Retia Medical was founded to commercialize hemodynamic monitoring technology developed at the University of Michigan, with a focus on making advanced cardiac output monitoring accessible and non-invasive. The company has built clinical evidence supporting Accuryn's accuracy versus reference standard thermodilution cardiac output measurement. Accuryn competes with hemodynamic monitoring systems from Edwards Lifesciences (FloTrac/Acumen), LiDCO (now part of Masimo), and Deltex Medical in the non-invasive and minimally invasive cardiac output monitoring segment.
Frequently Asked Questions
Similar Brands
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare Accuryn with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Accuryn? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Accuryn Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Accuryn vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →